Screener
SELLAS Life Sciences Group, Inc. SLS Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | $(8,407) | $(5,813) |
| Adjustment to reconcile net loss to net cash used in operating activities: | ||
| Non-cash stock-based compensation | 798 | 505 |
| Non-cash lease expense | 153 | 147 |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other assets | (652) | (1,132) |
| Accounts payable | 685 | 277 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is SELLAS Life Sciences Group, Inc.'s stock-based comp?
- SELLAS Life Sciences Group, Inc. (SLS) reported stock-based comp of $798K in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s stock-based comp changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s stock-based comp increased by 58.0% year-over-year, from $505K to $798K.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s stock-based comp?
- Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s stock-based comp has grown at a 17.9% compound annual growth rate (CAGR), from $1.01M to $1.96M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about SELLAS Life Sciences Group, Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude